HIGHLIGHTS
- who: Chiara Zanetta from the Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy have published the research: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study, in the Journal: Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132 Milan, Italy of /2013/
- what: The authors report real-world findings about effectiveness and tolerability of CLAD in a monocentric Italian cohort of RRMS patients, identifying early predictors of response and risk factors for suboptimal response to treatment.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.